Trial intelligence / Profile preview

Prothromplex Total for urgent reversal of vitamin K antagonist anticoagulation

2010-019250-41Phase 4Completed

Sponsor
Baxter International Inc.
Start
Apr 2010
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of Prothromplex Total in Acquired deficiency of prothrombin complex coagulation factors and prothrombin deficiency, sponsored by Baxter International Inc. Started Apr 2010; status: completed.

02

Drugs

Prothromplex Total
03

Conditions

Acquired deficiency of prothrombin complex coagulation factorsprothrombin deficiency

Beyond the preview

Go deeper on 2010-019250-41.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-019250-41.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call